Clinical trial
The Effect of the Parous Female and Young Male Donor on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG and PTCy for Haplo-HSCT: a Prospective, Multi-center, Cohort Study
NCT06686173 is registered in ClinicalTrials.gov with Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of the Parous Female and Young Male Donor on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG and PTCy for Haplo-HSCT: a Prospective, Multi-center, Cohort Study
- Lead sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2025
- Completion date
- February 1, 2028
- Enrollment
- 114 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
high-risk acute myeloid leukemia, relapse and/or refractory aml